Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of early analyses of activity in patients with oesophageal cancer during ...
Gastroenterological and hepatic disorders are prevalent worldwide, contributing significantly to healthcare utilisation and ...
Glomus tumours are uncommon, typically benign neoplasms of specialised dermal thermoregulatory structures known as glomus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback